Mesocarb efficiency in relieving asthenic conditions in patients taking antipsychotic drugs, as well as prospects of its use in pathologies of the brain dopaminergic system

Abstract

Mesocarb (sydnocarb, N-phenylcarbamoyl-3- (β-phenylisopropyl)-sydnonimine) is a drug belonging to the group of psychomotor stimulants, structurally similar to dextroamphetamine. The difference between this drug and d-amphetamine lies in a longer duration of action, the absence of euphoria in patients, as well as a reduced ability to form dependence and develop episodes of intoxication, which predisposes to its widespread use in the treatment of asthenic conditions. It can also be regarded as a promising drug for the treatment of Parkinson's disease and attention deficit hyperactivity disorder.